Specialized Living Wound Dressing Based on the Self-Assembly Approach of Tissue Engineering
Source abstract
Abstract
There is a high incidence of failure and recurrence for chronic skin wounds following conventional therapies. To promote healing, the use of skin substitutes containing living cells as wound dressings has been proposed. The aim of this study was to produce a scaffold-free cell-based bilayered tissue-engineered skin substitute (TES) containing living fibroblasts and keratinocytes suitable for use as wound dressing, while considering production time, handling effort during the manufacturing process, and stability of the final product. The self-assembly method, which relies on the ability of mesenchymal cells to secrete and organize connective tissue sheet sustaining keratinocyte growth, was used to produce TESs. Three fibroblast-seeding densities were tested to produce tissue sheets. At day 17, keratinocytes were added onto 1 or 3 (reference method) stacked tissue sheets. Four days later, TESs were subjected either to 4, 10, or 17 days of culture at the air–liquid interface (A/L). All resulting TESs were comparable in terms of their histological aspect, protein expression profile and contractile behavior in vitro. However, signs of extracellular matrix (ECM) digestion that progressed over culture time were noted in TESs produced with only one fibroblast-derived tissue sheet. With lower fibroblast density, the ECM of TESs was almost completely digested after 10 days A/L and lost histological integrity after grafting in athymic mice. Increasing the fibroblast seeding density 5 to 10 times solved this problem. We conclude that the proposed method allows for a 25-day production of a living TES, which retains its histological characteristics in vitro for at least two weeks.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Wound Healing and Treatments · Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Centre de Recherche en Organogénèse Expérimentale de l’Université Laval/LOEX, Regenerative Medicine Division, CHU de Québec-Université Laval Research Centre, Département de Chirurgie, Faculté de Médecine, Université Laval, 1401 18e Rue, Québec, Québec G1J 1Z4, Canada
Funding
Canadian Institutes of Health Research
References (46)
Show source-provided references
1. Human skin wounds: A major and snowballing threat to public health and the economy10.1111/j.1524-475X.2009.00543.x ↗
2. Zhou, K., Krug, K., and Brogan, M.S. (2015). Physical therapy in wound care: A cost–effectiveness analysis. Med. Baltim., 94.10.1097/MD.0000000000002202 ↗
3. Community leg ulcer clinics: Cost-effectiveness
4. Nelson, E.A., and Adderley, U. (2016, January 15). Venous leg ulcers, Available online: https://www.ncbi.nlm.nih.gov/pubmed/26771825.
5. Clinical and cost-effectiveness of compression hosiery versus compression bandages in treatment of venous leg ulcers (venous leg ulcer study iv, venus iv): A randomised controlled trial10.1016/S0140-6736(13)62368-5 ↗
6. Leg ulcers: Epidemiology and aetiology10.1002/bjs.1800730905 ↗
7. Venous leg ulcers: A prognostic index to predict time to healing10.1136/bmj.305.6862.1119 ↗
8. Factors associated with healing leg ulceration with high compression10.1093/ageing/24.5.407 ↗
9. Systematic review of skin graft donor-site dressings10.1097/PRS.0b013e3181a8072f ↗
10. Serra, R., Rizzuto, A., Rossi, A., Perri, P., Barbetta, A., Abdalla, K., Caroleo, S., Longo, C., Amantea, B., and Sammarco, G. (2016). Skin grafting for the treatment of chronic leg ulcers—A systematic review in evidence-based medicine. Int. Wound J.10.1111/iwj.12575 ↗
11. A bilayered living skin construct (apligraf) accelerates complete closure of hard-to-heal venous ulcers10.1046/j.1524-475X.1999.00201.x ↗
12. Wound-healing factors secreted by epidermal keratinocytes and dermal fibroblasts in skin substitutes10.1111/j.1524-475X.2007.00280.x ↗
13. A stable niche supports long-term maintenance of human epidermal stem cells in organotypic cultures10.1634/stemcells.2007-0991 ↗
14. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components10.1111/j.1067-1927.2004.012306.x ↗
15. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism10.1242/jcs.112.12.1843 ↗
16. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Human skin equivalent investigators group10.1001/archderm.134.3.293 ↗
17. A clinical investigation on the characteristics and outcomes of treating chronic lower extremity wounds using the tissuetech autograft system10.1177/1534734603258480 ↗
18. Jones, J.E., Nelson, E.A., and Al-Hity, A. (2013). Skin grafting for venous leg ulcers. Cochrane Database Syst. Rev., CD001737.10.1002/14651858.CD001737.pub4 ↗
19. A prospective, multicentre, randomised controlled study of human fibroblast-derived dermal substitute (dermagraft) in patients with venous leg ulcers10.1111/iwj.12053 ↗
20. The incidence of lower-extremity amputation and bone resection in diabetic foot ulcer patients treated with a human fibroblast-derived dermal substitute10.1097/01.ASW.0000456630.12766.e9 ↗
21. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: An interim analysis10.12968/jowc.2016.25.Sup7.S18 ↗
22. Extracellular matrix-based biomaterial scaffolds and the host response10.1016/j.biomaterials.2016.02.003 ↗
23. Foreign body reaction to biomaterials10.1016/j.smim.2007.11.004 ↗
24. Busscher, H.J., van der Mei, H.C., Subbiahdoss, G., Jutte, P.C., van den Dungen, J.J., Zaat, S.A., Schultz, M.J., and Grainger, D.W. (2012). Biomaterial-associated infection: Locating the finish line in the race for the surface. Sci. Transl. Med., 4.10.1126/scitranslmed.3004528 ↗
25. An overview of tissue and whole organ decellularization processes10.1016/j.biomaterials.2011.01.057 ↗
26. A human tissue-engineered vascular media: A new model for pharmacological studies of contractile responses10.1096/fj.00-0283com ↗
27. Characterization of a new tissue-engineered human skin equivalent with hair10.1007/s11626-999-0081-x ↗
28. Improved methods to produce tissue-engineered skin substitutes suitable for the permanent closure of full-thickness skin injuries10.1089/biores.2016.0036 ↗
29. Autologous bilayered self-assembled skin substitutes (sasss) as permanent grafts: A case series of 14 severely burned patients indicating clinical effectiveness10.22203/eCM.v036a10 ↗
30. Prospective study on the treatment of lower-extremity chronic venous and mixed ulcers using tissue-engineered skin substitute made by the self-assembly approach10.1097/01.ASW.0000433102.48268.2a ↗
31. Minimal contraction for tissue-engineered skin substitutes when matured at the air-liquid interface10.1002/term.543 ↗
32. A comparative analysis of skin substitutes used in the management of diabetic foot ulcers10.12968/jowc.2016.25.Sup10.S8 ↗
33. Autologous skin substitute for hard-to-heal ulcers: Retrospective analysis on safety, applicability, and efficacy in an outpatient and hospitalized setting10.1111/wrr.12082 ↗
34. Cultured skin as a ‘smart material’ for healing wounds: Experience in venous ulcers10.1016/0142-9612(96)85569-4 ↗
35. From newborn to adult: Phonotypic and functional properties of skin equivalent and human skin as a function of donor age10.1002/(SICI)1097-4652(199705)171:2<179::AID-JCP8>3.0.CO;2-L ↗
36. Inexpensive production of near-native engineered stromas10.1002/term.2036 ↗
37. Aprotinin inhibits unspecific degradation of collagen in rat and human pancreas10.1007/BF02788376 ↗
38. Human keratinocytes cultured on collagen matrix used as an experimental burn model
39. The microvasculature is the critical target of the immune response in vascularized skin allograft rejection10.1111/1523-1747.ep12543418 ↗
40. Rejection of first-set skin allografts in man. The microvasculature is the critical target of the immune response10.1084/jem.150.2.322 ↗
41. Acceptance of allogeneic fibroblasts in skin equivalent transplants10.1097/00007890-198311000-00015 ↗
42. Composite autologous-allogeneic skin replacement: Development and clinical application10.1097/00006534-198710000-00029 ↗
43. Analysis of cellular and decellular allogeneic dermal grafts for the treatment of full-thickness wounds in a porcine model10.1097/00005373-199709000-00012 ↗
44. Regeneration of skin and cornea by tissue engineering10.1007/978-1-59745-060-7_15 ↗
45. Irradiated human dermal fibroblasts are as efficient as mouse fibroblasts as a feeder layer to improve human epidermal cell culture lifespan10.3390/ijms14034684 ↗
46. In vivo evaluation and imaging of a bilayered self-assembled skin substitute using a decellularized dermal matrix grafted on mice10.1089/ten.tea.2016.0296 ↗